Business Context and Reporting Period
This Form 8-K, filed on December 14, 2023, by Chavant Capital Acquisition Corp. (CLAY), details material definitive agreements regarding its proposed business combination with Mobix Labs, Inc. Upon closing, the combined entity will be named Mobix Labs, Inc. The filing reports on Private Investment in Public Equity (PIPE) transactions and related capital structure adjustments necessary to satisfy the Minimum Cash Condition for the merger.
Key Financial Metrics and Capital Structure
The filing focuses on capital raising rather than historical operating performance. Key financial terms include:
- Sage Hill PIPE Investment: $15,000,000 for 1,500,000 shares of Class A Common Stock at $10.00 per share.
- Sponsor PIPE Investment: $1,997,370 for 199,737 shares of Class A Common Stock at $10.00 per share, paid via the forgiveness of existing obligations.
- Forgiven Obligations: Approximately $1,997,370 in working capital loans and reimbursement obligations owed to the Sponsor will be extinguished.
- Additional PIPE Commitments: One investor has agreed to fund $500,000; another has indicated preparedness to fund $3,000,000 (subject to execution).
- Liquidity Requirement: Management believes at least $15,000,000 in funding must be preserved for post-closing operations.
The filing does not provide specific revenue, profit, or cash flow figures for Mobix Labs or Chavant.
Material Changes and Transaction Mechanics
Significant structural changes are being implemented to facilitate the merger:
- Warrant Issuances: Mobix Labs issued a warrant to Sage Hill for 1,500,000 shares at $0.01 exercise price. A Sponsor Warrant for 272,454 shares at $0.01 exercise price is expected to be issued.
- Sponsor Forfeitures: The Sponsor is expected to forfeit 658,631 Founder Shares and 400,000 Private Warrants upon closing.
- Warrant Price Adjustment: Due to the PIPE issuance price ($10.00) being below the $9.20 threshold relative to market conditions, existing public warrants may be subject to a price adjustment if the 10-day VWAP is below $9.20. The exercise price would adjust to 115% of the higher of the Market Value or Newly Issued Price.
Outlook, Risks, and Contingencies
Management is actively managing liquidity and transaction conditions:
- Minimum Cash Condition: The closing is contingent on meeting a minimum cash threshold. The company is seeking additional financing and discussing with public shareholders the potential withdrawal of redemption elections to increase available cash.
- Dilution Risk: Additional PIPE investments or shareholder redemption withdrawals may result in further dilution to existing shareholders.
- Execution Risk: There is no assurance that the $3.0 million Additional PIPE will be executed or that the Minimum Cash Condition will be waived if funding falls short.
- Forward-Looking Risks: Risks include failure to complete the transaction, inability to achieve profitability, commercialization delays for semiconductor products, and potential volatility in the stock price due to macroeconomic factors and U.S./China trade tensions.
Investor Verification Checklist
- Verify the final status of the $3.0 million Additional PIPE commitment and whether it has been fully executed.
- Confirm the total cash available at closing to ensure the Minimum Cash Condition is satisfied or formally waived.
- Review the definitive Proxy Statement/Prospectus (File No. 333-271197) for detailed terms of the warrant price adjustment provision.
- Monitor shareholder redemption rates to assess potential dilution from share issuances to redeeming shareholders.
- Check for updates on the Sponsor's forfeiture of Founder Shares and Private Warrants upon the transaction closing.